Literature DB >> 25950593

Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?

Rafael Lanaro1, Débora Bressanim de Aquino Calemi, Loraine Rezende Togni, José Luiz Costa, Maurício Yonamine, Silvia de Oliveira Santos Cazenave, Alessandra Linardi.   

Abstract

The ritualistic use of ayahuasca is becoming a global phenomenon. This beverage contains a combination of monoamine oxidase inhibitors (harmine, harmaline, and tetrahydroharmine) and N,N-dimethyltryptamine, the main substance responsible for its visionary effect. The recreational use of similar alkaloids and N,N-dimethyltryptamine has increased in recent years, mainly because of their hallucinogenic effects. In the present study, the concentrations of psychoactive alkaloids in three powder samples seized by the São Paulo State Police and nine ayahuasca aqueous extracts were analyzed by HPLC-DAD in an attempt to distinguish between illicit drugs and the religious beverage. The alkaloids detected (μg/mL) in the ayahuasca aqueous extracts were N,N-dimethyltryptamine (402-2070.3), harmaline (27.5-181.3), harmine (294.5-2893.8), and tetrahydroharmine (849.5-2052.5), whereas, of the three powder samples, one contained only N,N-dimethyltryptamine (82% and 2% w/w, respectively) while the other contained only harmaline (16%, w/w) and harmine (12%, w/w). The ritualistic use of ayahuasca involves oral intake and the probability of overdose is minimized by serotonergic stimulation of vagal pathways, leading to vomiting and diarrhea. In contrast, the recreational use of N,N-dimethyltryptamine involves consumption mainly by smoking or inhalation, both of which markedly increase its bioavailability and the potential for intoxications.

Entities:  

Keywords:  HPLC-DAD; ayahuasca; beta-carboline alkaloids; dimethyltryptamine; forensic toxicology; illicit drugs

Mesh:

Substances:

Year:  2015        PMID: 25950593     DOI: 10.1080/02791072.2015.1013202

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  13 in total

1.  Ayahuasca: An ancient sacrament for treatment of contemporary psychiatric illness?

Authors:  Benjamin J Malcolm; Kelly C Lee
Journal:  Ment Health Clin       Date:  2018-03-23

2.  Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Authors:  Adam L Halberstadt
Journal:  Pharmacol Biochem Behav       Date:  2016-01-15       Impact factor: 3.533

Review 3.  Neuropharmacology of N,N-dimethyltryptamine.

Authors:  Theresa M Carbonaro; Michael B Gatch
Journal:  Brain Res Bull       Date:  2016-04-25       Impact factor: 4.077

4.  Ceremonial "plant medicine" use and its relationship to recreational drug use: an exploratory study.

Authors:  Caroline Dorsen; Joseph Palamar; Michele G Shedlin
Journal:  Addict Res Theory       Date:  2018-03-30

5.  Behavioral Changes Over Time Following Ayahuasca Exposure in Zebrafish.

Authors:  Robson Savoldi; Daniel Polari; Jaquelinne Pinheiro-da-Silva; Priscila F Silva; Bruno Lobao-Soares; Mauricio Yonamine; Fulvio A M Freire; Ana C Luchiari
Journal:  Front Behav Neurosci       Date:  2017-07-28       Impact factor: 3.558

6.  Chronic intermittent exposure to ayahuasca during aging does not affect memory in mice.

Authors:  N F Correa-Netto; L S Coelho; G S Galfano; F Nishide; F Tamura; M K Shimizu; J G Santos; A Linardi
Journal:  Braz J Med Biol Res       Date:  2017-06-05       Impact factor: 2.590

7.  An ontogenic study of the behavioral effects of chronic intermittent exposure to ayahuasca in mice.

Authors:  N F Correa-Netto; M Y Masukawa; F Nishide; G S Galfano; F Tamura; M K Shimizo; M P Marcato; J G Santos; A Linardi
Journal:  Braz J Med Biol Res       Date:  2017-06-05       Impact factor: 2.590

Review 8.  Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.

Authors:  Jonathan Hamill; Jaime Hallak; Serdar M Dursun; Glen Baker
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363

9.  Stability Evaluation of DMT and Harmala Alkaloids in Ayahuasca Tea Samples.

Authors:  Gabriela de Oliveira Silveira; Rafael Guimarães Dos Santos; Felipe Rebello Lourenço; Giordano Novak Rossi; Jaime E C Hallak; Mauricio Yonamine
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

10.  Ayahuasca and Its DMT- and β-carbolines - Containing Ingredients Block the Expression of Ethanol-Induced Conditioned Place Preference in Mice: Role of the Treatment Environment.

Authors:  Elisangela G Cata-Preta; Yasmim A Serra; Eliseu da C Moreira-Junior; Henrique S Reis; Natali D Kisaki; Matheus Libarino-Santos; Raiany R R Silva; Thaísa Barros-Santos; Lucas C Santos; Paulo C R Barbosa; José L Costa; Alexandre J Oliveira-Lima; Lais F Berro; Eduardo A V Marinho
Journal:  Front Pharmacol       Date:  2018-05-29       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.